Moreover, in this same study, targeting H19 inhibited tumor metastases by approximately eight-fold in comparison with that of controls, suggesting that H19 may be a potential target for molecular therapy in anaplastic cancer patients. This evidence concerns the gene H19 and anaplastic cancer.